Depo-Provera Lawsuit Side Effects: 2026 Full Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.

Thousands of women are now filing lawsuits over Depo-Provera lawsuit side effects, and the most serious claim links this birth control shot to meningioma brain tumors. By 2026, the litigation has grown into one of the largest pharmaceutical mass torts in the country.

If you used Depo-Provera and developed a brain tumor or other serious health problems, this article covers everything you need to know. You’ll find the latest case updates, settlement estimates, eligibility rules, filing steps, and deadlines.

Here’s a number that stopped people in their tracks: a major French study found that prolonged Depo-Provera use increased meningioma risk by up to 5.6 times. That single finding helped ignite this entire wave of litigation.

You might also find this useful — James Henry Lawsuit 2026: Full Settlement and Claim Guide

This guide is current through 2026 and built to answer every question you have about this case.

Depo-Provera Lawsuit Side Effects Overview

Depo-Provera lawsuit side effects refer to the health problems that women experienced after receiving the birth control injection, with meningioma brain tumors at the center of the legal claims. Lawsuits allege that Pfizer knew about these risks and failed to warn patients or doctors properly.

The active ingredient in Depo-Provera is medroxyprogesterone acetate, a synthetic progestin. Women receive the shot every three months. Some used it for years or even decades.

The side effects driving lawsuits go beyond brain tumors. Plaintiffs have reported:

• Meningioma brain tumors (the primary claim)
• Significant bone density loss
• Severe hormonal disruption
• Blood clots and cardiovascular events
• Depression and mood disorders
• Prolonged infertility after stopping the drug

The core legal argument is straightforward. Pfizer had data suggesting a link between prolonged progestin exposure and brain tumor growth. Plaintiffs say the company buried that information instead of updating warning labels.

Depo-Provera Meningioma Lawsuit Explained

The Depo-Provera meningioma lawsuit is a mass tort action alleging that long-term use of the contraceptive injection causes meningioma, a type of brain tumor that grows in the membranes surrounding the brain and spinal cord. Meningiomas are usually classified as benign, but that word is misleading.

Even “benign” meningiomas can cause seizures, vision loss, hearing damage, and severe headaches. Many require brain surgery to remove. Some grow back after surgery, forcing patients into repeated operations.

The scientific connection is rooted in how meningiomas behave. These tumors have progesterone receptors on their surfaces. When a woman takes Depo-Provera, she floods her body with synthetic progesterone every 90 days. The theory, backed by growing research, is that this hormone exposure feeds tumor growth.

A landmark 2024 study published through French national health insurance data examined over 100,000 women. It found:

• 1 year of use: moderate increase in meningioma risk
• 3 or more years of use: risk increased by 5.6 times
• Risk persisted even after women stopped using the drug

Pfizer’s predecessor company, The Upjohn Company, originally developed Depo-Provera in the 1960s. The drug received FDA approval in 1992. Plaintiffs argue that decades of available research should have prompted earlier warnings.

Key Takeaway: The Depo-Provera meningioma lawsuit centers on scientific evidence showing that prolonged use of the birth control shot dramatically increases the risk of developing brain tumors.

Depo-Provera Lawsuit Update for 2026

As of 2026, the Depo-Provera litigation has been consolidated into a multidistrict litigation (MDL) in federal court. Hundreds of individual cases are now grouped together for pretrial proceedings. The case count continues to climb every month.

Here’s where things stand this year:

The MDL is assigned to the U.S. District Court for the Northern District of Alabama. Bellwether trials, which are test cases chosen to represent the larger group, are being selected now. These trials will set the tone for settlement negotiations.

Discovery is the phase where both sides exchange evidence. Plaintiffs’ attorneys are seeking internal Pfizer documents about what the company knew and when. Those documents could make or break the case.

No global settlement has been announced yet. That’s typical for this stage. Most pharmaceutical mass torts don’t reach settlement discussions until after at least one bellwether trial verdict comes in. Think of bellwether trials as the opening hand in a poker game; they show both sides what the cards look like.

Depo-Provera Lawsuit Settlement Amounts

Depo-Provera lawsuit settlement amounts have not been officially determined yet, but legal experts project a wide range based on the severity of each plaintiff’s injuries. Individual settlements could range from $100,000 to over $1 million depending on the case.

Several factors will influence how much each plaintiff receives:

• Type and size of meningioma
• Whether surgery was required
• Number of surgeries or treatments
• Lasting neurological damage
• Duration of Depo-Provera use
• Age of the plaintiff at diagnosis
• Lost wages and medical expenses

These estimates are based on comparable pharmaceutical settlements in similar mass tort cases. The Zantac litigation and talcum powder lawsuits provide reference points, though every case is different.

No one can guarantee a specific dollar amount right now. Settlements depend on trial outcomes, Pfizer’s willingness to negotiate, and the strength of each individual claim. Plaintiffs with strong medical records and clear links between their Depo-Provera use and their diagnosis will likely receive higher compensation.

Who Qualifies for the Depo-Provera Lawsuit?

You may qualify for the Depo-Provera lawsuit if you received one or more Depo-Provera injections and later developed a meningioma or other serious health condition linked to the drug. The strongest claims involve women who used the shot for a year or longer.

Here are the basic eligibility criteria most law firms are using:

• You received Depo-Provera or Depo-SubQ Provera 104 injections
• You were diagnosed with a meningioma brain tumor
• Your meningioma was diagnosed during or after your use of the drug
• You have medical records confirming both the injections and the diagnosis

Women who used Depo-Provera for shorter periods may still qualify. The key is a documented diagnosis. If you had a meningioma removed and later learned about the Depo-Provera connection, you might have a valid claim even if years have passed.

Family members of women who died from meningioma complications after Depo-Provera use may be eligible to file wrongful death claims.

Key Takeaway: If you used Depo-Provera and were diagnosed with a meningioma, you likely qualify to file a claim, especially if you have medical records proving both the drug use and the diagnosis.

Depo-Provera Brain Tumor Lawsuit Details

The Depo-Provera brain tumor lawsuit specifically targets the relationship between the synthetic progestin in the injection and the development of meningioma tumors in the brain. Plaintiffs argue that Pfizer failed to warn about this risk despite having access to research showing the connection.

Meningiomas grow from the meninges, the protective layers around the brain. They account for roughly 40% of all primary brain tumors. While most are classified as WHO Grade 1 (benign), their location in the skull makes them dangerous regardless of grade.

Key facts about these brain tumor claims:

• Meningiomas are the most common primary brain tumor in adults
• They are 3 times more common in women than men
• Progesterone receptor expression is found in roughly 70% of meningiomas
• Depo-Provera delivers 150 mg of synthetic progesterone per injection

The lawsuits point to a troubling timeline. Research connecting progestin-containing drugs to meningioma risk has existed since the early 2000s. European regulators took action before the FDA. France restricted certain progestin drugs in 2020 after accumulating evidence.

Pfizer’s legal defense is expected to argue that meningiomas can occur naturally and that the drug’s labeling was adequate under existing FDA guidelines. Plaintiffs counter that “adequate” isn’t the same as “honest.”

Depo-Provera Side Effects Long Term

Long-term Depo-Provera side effects extend well beyond what most women were told when they started the injection. Years of use can produce lasting health consequences that persist even after stopping the drug.

The most commonly reported long-term side effects include:

• Bone mineral density loss (can take years to recover, if at all)
• Meningioma brain tumors (risk increases with duration of use)
• Delayed return of fertility (average 10 months after last injection)
• Weight gain (average of 5 to 10 pounds per year of use)
• Persistent mood changes including depression and anxiety
• Cardiovascular risks including blood clots

What makes the long-term effects particularly concerning is their cumulative nature. Each injection delivers a massive dose of synthetic progesterone that suppresses the body’s natural hormonal cycle. Over years, this suppression affects bone health, brain tissue, mood regulation, and reproductive function.

Many women report that their doctors never discussed these long-term risks. That failure of informed consent is a central argument in the lawsuits.

Depo-Provera Meningioma Symptoms to Watch For

Depo-Provera meningioma symptoms can be subtle at first, often mimicking other conditions like migraines or stress. That’s exactly why many women don’t get diagnosed until the tumor has grown significantly.

Watch for these warning signs:

• Persistent headaches that worsen over time
• Vision changes, including blurriness or double vision
• Hearing loss or ringing in the ears (tinnitus)
• Seizures with no prior history of epilepsy
• Weakness or numbness in the arms or legs
• Memory problems or difficulty concentrating
• Changes in smell

The tricky part is that meningiomas grow slowly. A woman might experience mild headaches for years before anyone considers a brain scan. By the time the tumor shows up on an MRI, it may already be large enough to require surgical removal.

If you used Depo-Provera for a year or more and experience any combination of these symptoms, request a brain MRI. Early detection can mean the difference between monitoring and emergency surgery.

Key Takeaway: Meningioma symptoms often start as mild headaches or vision changes, so any woman who used Depo-Provera long-term and notices these signs should request brain imaging immediately.

Depo-Provera Lawsuit Eligibility Requirements

Depo-Provera lawsuit eligibility requirements come down to three core elements: proof you took the drug, proof you developed a qualifying medical condition, and a timeline that connects the two. Meeting all three puts you in the strongest position to file.

The detailed eligibility checklist:

• Drug use: You received at least one Depo-Provera or Depo-SubQ Provera 104 injection. Longer use strengthens eligibility.
• Medical condition: You were diagnosed with a meningioma brain tumor (any WHO grade). Other serious conditions like significant bone density loss may qualify separately.
• Timeline: Your diagnosis occurred during or after your period of Depo-Provera use. There is no minimum gap requirement.
• Documentation: You can provide medical records, pharmacy records, or insurance billing that confirms both the drug use and the diagnosis.

What if you don’t have your old medical records? Don’t give up. Pharmacies typically retain prescription records for 10 years or more. Hospital systems keep patient records even longer. Your insurance company likely has billing records showing the injections.

Women who were diagnosed with meningioma and had their tumors removed before the lawsuits became public may still be eligible. The key is establishing that you used Depo-Provera and that you had the diagnosis.

Also worth exploring: Finance Lawsuit April 2026: Settlement and Payout Updates

How to File a Depo-Provera Lawsuit

Filing a Depo-Provera lawsuit starts with contacting a law firm that handles pharmaceutical mass tort cases. Most firms offer free case evaluations, and attorneys in this litigation work on contingency, meaning they only get paid if you win.

Step-by-step filing process:

1. Contact a mass tort attorney for a free case review
2. Gather your medical records showing Depo-Provera use
3. Collect your diagnostic records confirming meningioma or other qualifying condition
4. Provide your personal health history to the attorney
5. Sign a retainer agreement if the firm accepts your case
6. Your attorney files the complaint in the MDL or appropriate state court
7. Participate in discovery as needed (depositions, medical exams)

You won’t pay any upfront fees. Contingency fee arrangements mean the attorney takes a percentage (usually 33% to 40%) of your settlement or verdict. If you don’t recover money, you owe nothing.

One important detail: do not wait to contact an attorney just because you think you need perfect records. Experienced firms have teams dedicated to tracking down medical documentation. Start the conversation now and let them help fill in the gaps.

Depo-Provera MDL Status in 2026

The Depo-Provera MDL (multidistrict litigation) is an active federal case in 2026, consolidated under MDL No. 3127 in the U.S. District Court for the Northern District of Alabama. The MDL structure allows hundreds of individual cases to share pretrial proceedings while keeping each plaintiff’s claim separate.

Here’s what the MDL process looks like:

Think of an MDL like a highway merger. Hundreds of individual cars (cases) converge into one road (court) to move through traffic (pretrial proceedings) more efficiently. Once the pretrial work is done, cases can either settle globally or return to their original courts for individual trials.

The bellwether trial selection is the most important development happening right now. Both sides are choosing representative cases that will be tried first. These early verdicts will heavily influence whether Pfizer decides to settle and for how much.

Plaintiffs’ attorneys have requested internal documents from Pfizer regarding what the company knew about the meningioma risk. If damaging internal communications surface during discovery, they could dramatically strengthen the plaintiffs’ position.

Key Takeaway: The Depo-Provera MDL is actively moving through discovery in 2026, with bellwether trials expected to begin by late 2026 or early 2027, setting the stage for potential settlement talks.

Depo-Provera and Bone Density Loss

Depo-Provera causes measurable bone density loss, and the FDA has acknowledged this risk since 2004 with a black box warning on the drug’s label. For many women, this bone loss begins within the first two years of use and may not fully reverse after stopping the drug.

The mechanism is straightforward. Depo-Provera suppresses estrogen production. Estrogen protects bones. Without adequate estrogen, bones lose mineral density faster than they rebuild.

Key facts about Depo-Provera and bone health:

• Average bone density loss: 5% to 6% after 2 years of use
• FDA recommendation: Do not use for longer than 2 years
• Recovery: Partial recovery occurs after stopping, but may take 2 to 3 years
• Populations at highest risk: Adolescents and women over 40

Despite the black box warning, many women report that their healthcare providers never discussed the bone density risk. Some used the drug for five, ten, or even fifteen years without being told about the two-year limit.

This is relevant to the lawsuit because it shows a pattern. If Pfizer and prescribing doctors minimized one known risk (bone loss), plaintiffs argue, it’s reasonable to believe they minimized or ignored other risks too, including meningioma.

Depo-Provera Hormonal Side Effects

Depo-Provera hormonal side effects stem from the drug’s mechanism of suppressing natural hormone cycles with a large dose of synthetic progestin delivered every 90 days. This hormonal disruption can affect nearly every system in a woman’s body.

The injection delivers 150 mg of medroxyprogesterone acetate in a single dose. For context, most oral progestin pills contain 0.35 mg to 10 mg daily. The concentrated dose from the shot creates a hormonal environment that is dramatically different from a woman’s natural cycle.

Reported hormonal side effects include:

• Irregular or absent menstrual periods
• Weight gain, especially around the midsection
• Mood swings, depression, and anxiety
• Decreased libido
• Acne and skin changes
• Hair thinning
• Fatigue and low energy

What many women don’t realize is that these hormonal effects can linger for months after the last injection. Unlike a pill you can simply stop taking, the depot injection sits in your muscle tissue and slowly releases the drug. You can’t undo an injection once it’s given.

This “locked-in” nature of the drug is another argument plaintiffs raise. They couldn’t quickly reverse course when side effects appeared.

Key Takeaway: Depo-Provera’s concentrated hormonal dose causes widespread side effects that can persist long after the last injection, and women were rarely given complete information about these risks before starting the drug.

Depo-Provera FDA Warnings and Label Changes

The FDA has issued several warnings about Depo-Provera over the years, but critics say each warning came too late and didn’t go far enough. The agency’s history with this drug reveals a pattern of slow, incremental responses to mounting safety evidence.

Timeline of FDA actions:

The 2004 black box warning was significant. It’s the strongest warning the FDA can require short of pulling a drug from the market. But that warning only addressed bone loss. It said nothing about brain tumors.

By the time the French national health insurance study revealed the 5.6-fold increase in meningioma risk for long-term users, millions of women worldwide had already used the drug for years. The study analyzed data from over 100,000 women and was published in the BMJ (British Medical Journal).

European regulators acted faster than the FDA on the meningioma issue. France restricted certain high-dose progestin medications before the U.S. took any regulatory steps.

Plaintiffs argue that the FDA’s warning history proves Pfizer repeatedly had to be forced into disclosing risks. Each warning came only after external pressure from studies, lawsuits, or international regulators rather than voluntary transparency.

Depo-Provera Lawsuit Statute of Limitations

The statute of limitations for a Depo-Provera lawsuit varies by state, but most states allow between 1 and 6 years from the date you discovered (or should have discovered) that Depo-Provera caused your injury. This “discovery rule” is critical because many women were diagnosed with meningioma long before the lawsuits made the connection public.

The discovery rule works like this. Say you had a meningioma removed in 2018 but didn’t learn about the Depo-Provera connection until 2024 when the lawsuits were publicized. Your statute of limitations clock likely starts in 2024, not 2018.

This is good news for many potential plaintiffs. Without the discovery rule, women who were diagnosed years ago would be shut out of the litigation.

However, every state also has a “statute of repose,” which sets an absolute outer deadline regardless of when you discovered the connection. These vary widely, from 10 to 15 years in most states.

Worth reading: Vape Lawsuit 2026: Payouts, Deadlines, and Claims

Do not assume you’ve missed the deadline. Contact an attorney to check your specific state’s rules. Many women who think they’re too late are actually well within their filing window.

A closely related topic: Live Olympics Lawsuit 2026: Settlement and Filing Update

Depo-Provera Settlement Payout Timeline

Depo-Provera settlement payouts are not expected to begin before late 2027 at the earliest, based on the current pace of the litigation. Mass tort cases of this size typically take 3 to 5 years from MDL formation to the first settlement checks reaching plaintiffs.

Here’s a realistic timeline:

Why does it take so long? Think of it like building a house. You can’t put up walls before the foundation is poured. The bellwether trials are the foundation. Until a jury delivers a verdict, Pfizer has little incentive to settle. After a large verdict, the math changes dramatically.

Each plaintiff’s payout timing will depend on:

• When they filed their claim
• The complexity of their medical evidence
• Whether they’re part of the MDL or a state court case
• The terms of any global settlement agreement

If history is any guide, the first payments will go to plaintiffs with the most severe injuries, specifically those who had brain surgery or multiple surgeries. Lower-tier claims (monitoring cases, bone density loss) will likely be resolved later in the process.

Filing early matters. Plaintiffs who file sooner are typically positioned better in the settlement queue. Waiting doesn’t help your case and may hurt your timeline for receiving compensation.

Key Takeaway: The first Depo-Provera settlement payouts likely won’t arrive until 2028, so filing your claim now is the best way to secure your place in line.

Depo-Provera: Class Action vs. Mass Tort

The Depo-Provera litigation is a mass tort, not a class action. The difference matters because it directly affects how much money you could receive and how your case is handled. In a mass tort, each plaintiff’s case is treated individually, which usually results in higher payouts for people with serious injuries.

Here’s an analogy. A class action is like splitting a pizza equally among 50 people; everyone gets the same tiny slice. A mass tort is like ordering individually; the person with the biggest appetite (most serious injury) gets a bigger meal.

In the Depo-Provera mass tort:

• Your medical records matter. Your payout depends on your specific diagnosis, treatment, and damages.
• You have your own attorney. Your lawyer represents you individually, not a faceless group.
• Your settlement is negotiated based on your injuries. Someone who had brain surgery will receive far more than someone with a small, monitored tumor.

This is why gathering your medical documentation early is so valuable. The strength of your individual case determines your individual outcome. You’re not just a number in a class; you’re a plaintiff with a unique story and unique damages.

Frequently Asked Questions

What side effects of Depo-Provera are part of the lawsuit?

The primary side effect in the lawsuit is meningioma, a type of brain tumor.

Other side effects being claimed include significant bone density loss, blood clots, and severe hormonal disruption.

The strongest legal claims involve women diagnosed with meningioma after long-term Depo-Provera use.

How much money could I get from a Depo-Provera lawsuit?

Estimated settlements range from $100,000 to over $1 million depending on injury severity.

Women who required brain surgery for meningioma are expected to receive the highest payouts.

Final amounts will depend on bellwether trial results and Pfizer’s settlement strategy.

Is there a deadline to file a Depo-Provera lawsuit in 2026?

Yes, but the deadline varies by state, typically 1 to 6 years from when you discovered the connection between Depo-Provera and your injury.

The discovery rule may extend your deadline if you only recently learned about the link.

Contact an attorney to check your specific state’s filing deadline.

How do I know if I qualify for the Depo-Provera lawsuit?

You likely qualify if you received Depo-Provera injections and were later diagnosed with a meningioma brain tumor.

Having medical records confirming both the drug use and the diagnosis strengthens your claim.

Women who used the drug for one year or longer are in the strongest position.

When will Depo-Provera lawsuit settlements be paid out?

The first settlement payouts are expected in late 2027 or 2028 at the earliest.

Bellwether trials must happen first before Pfizer is likely to negotiate a global settlement.

Filing your claim early helps secure your position in the payout queue.

The Depo-Provera lawsuit is one of the most significant pharmaceutical cases moving through the courts right now. If you used this birth control shot and developed a meningioma or other serious side effect, your window to act is open.

Gather your medical records. Check your state’s filing deadline. Connect with a mass tort attorney who can evaluate your case at no upfront cost.

This litigation is building momentum, and the women who file early will be positioned best when settlement negotiations begin.

Along the same lines: How Long Will the Zantac Lawsuit Take? 2026 Guide

Before you go further, consider reading Belviq Cancer Lawsuit: 2026 Guide to Claims & Payouts

See also: Education Lawsuit Last Week: 2026 Payout and Filing Guide

Never Miss a Lawsuit Update

Mark Lawfold as a Preferred Source so you never miss a settlement deadline or new filing.